NFE2L2 and cancer: Nuclear factor-erythroid 2-related factor 2 (NRF2), derived from the redox system, is the main regulatory factor in the cellular antioxidant response, with increasing evidence suggesting that NRF2 plays a role in the progression, metastasis, and therapeutic resistance of various cancers (Rojo de la Vega et al., 2018).